Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | -1.39% | -10.69% | -23.66% |
04-22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
04-12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.66% | 5.76M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Adial Pharmaceuticals Appoints Tony Goodmans as Chief Operating Officer